TICKERNERD
Menu
RXORXOIndustrials · Trucking

RXO Stock Forecast: RXO, Inc. Price Predictions for 2026-2027

Last close, 30 Oct 2026
$27
−0.58% on the day

The 18 Wall Street analysts covering RXO, Inc. hold a median 12-month price target of $30 — +9.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 72 of 100 as at 31 Oct 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$4.5B
Ticker Nerd rank
72/ 100
Median analyst target
$30
Analysts covering
18
Revenue$1.8B+25.0% y/y
Operating income$12.0M
Net income−$9.0M
Free cash flow−$52.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−4.4%
1M
+34.4%
YTD
+117.5%
1Y
+59.1%
From 52W high
−6.2%
From 52W low
+162.3%
$10
$29
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

RXO stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores RXO, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 31 Oct 2026
72/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
95
Momentum
84
Value
70
Quality
68
Accruals
55
Growth
43
Volatility
43
Issuance
34
Size
24

Revisions (95): Analysts have, on balance, been raising their forecasts.

Issuance (34): The company has been issuing shares or taking on financing, diluting existing holders.

Size (24): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

RXO stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on RXO, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25$30$35Jan 26Apr 26Jul 26Oct 26RXOHigh $33Median $30Low $19

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says18 analysts
3 Buy15 Hold0 Sell
Low $19Median $30High $33

The green dot is the last close — the median target sits +9.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
7 Oct 2026Truist SecuritiesMaintainsBuy$28 → $30
6 Oct 2026CitigroupMaintainsNeutral$23 → $30
6 Oct 2026JefferiesDowngradeHold$30
6 Oct 2026JP MorganUpgradeNeutral$22 → $30
6 Oct 2026TD CowenUpgradeHold$18 → $30
6 Oct 2026Wells FargoMaintainsEqual-Weight$23 → $30
23 Sept 2026SusquehannaUpgradeNeutral—
23 Sept 2026SusquehannaUpgradeNeutral$20 → $19
9 Sept 2026Wells FargoMaintainsEqual-Weight$22 → $23
9 Sept 2026Wells FargoMaintainsEqual-Weight—
7 Aug 2026CitigroupMaintainsNeutral$30 → $23
7 Aug 2026CitigroupMaintainsNeutral—
7 Aug 2026CitizensUpgradeMarket Outperform$30
7 Aug 2026CitizensUpgradeMarket Outperform—
7 Aug 2026TD CowenMaintainsSell—
7 Aug 2026TD CowenMaintainsSell$19 → $18
7 Aug 2026Truist SecuritiesMaintainsBuy$30 → $28
7 Aug 2026Truist SecuritiesMaintainsBuy—
7 Aug 2026UBSMaintainsNeutral$26 → $23
7 Aug 2026UBSMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

RXO appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

RXO vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 30 Oct 2026, RXO, Inc. returned +59.1% against +12.4% for the S&P 500, dividends included.

RXO vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140160180Jan 26Apr 26Jul 26Oct 26RXOS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

RXO analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+111.1%
Analysts raising
9
Analysts cutting
0
Fundamentals

RXO, Inc. (RXO) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
645.3×

Cheaper than 1% of US stocks

Price / sales
0.7×

Cheaper than 75% of US stocks

Price / book
3.0×

Cheaper than 30% of US stocks

EV / EBITDA
45.1×

Cheaper than 5% of US stocks

Growth & margins
Revenue growth (YoY)
31.7%

Higher than 79% of US stocks

Earnings growth (YoY)
25.0%

Higher than 63% of US stocks

Gross margin
12.6%

Higher than 12% of US stocks

Operating margin
1.3%

Higher than 47% of US stocks

Net margin
−1.3%

Higher than 28% of US stocks

Returns & dividend
Return on equity
−5.7%

Higher than 39% of US stocks

Return on assets
0.1%

Higher than 44% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

RXO, Inc. (RXO) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • RXO, Inc. has a market value of $4.5B and an enterprise value of $5.2B.

  • Revenue in the twelve months to 30 June 2026: $6.1B. The latest quarter grew 31.7% year on year.

  • Net income over the same four quarters: −$105.0M, a −1.7% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.61.

  • Free cash flow in the twelve months to 30 June 2026: −$76.0M.

  • Shares outstanding: 164.9M.

  • Trailing P/E: 645.3×; forward P/E: 42.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • RXO, Inc. employs 6,906 people — $882K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 31 Oct 2026

Data provided by Twelve Data

Peers

RXO vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelTrucking
CompanyMarket capTKN rank
RXORXO, Inc.$4.5B72
SNDRSchneider National, Inc.$5.1B78
ARCBArcBest Corp.$2.8B91
SAIASaia, Inc.$9.2B67
KNXKnight-Swift Transportation Holdings, Inc.$9.9B81
WERNWerner Enterprises, Inc.$1.7B47
MRTNMarten Transport Ltd.$957.1M53

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own RXO, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest RXO news & analysis

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)

GlobeNewsWire · 30 Oct 2026neutral

Brodsky & Smith announced that it is reminding investors about an investigation involving RXO Inc., alongside investigations involving ADT, PTC and Lifecore Biomedical. The notice invites RXO shareholders to contact the firm to discuss the investigation.

Why it matters — RXO shareholders may wish to note the announced investigation and the firm’s invitation to discuss it.

RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks Investment Research · 29 Oct 2026neutral

Zacks says RXO’s headline Q3 results for the quarter ended September 2026 offer a view of its performance. The excerpt suggests comparing key metrics with Wall Street estimates and year-ago actuals but provides no figures or comparison outcomes.

Why it matters — Those comparisons could help RXO watchers assess quarterly performance, but the excerpt does not report their results.

RXO (RXO) Q3 Earnings and Revenues Top Estimates

Zacks Investment Research · 29 Oct 2026positive

RXO reported quarterly earnings of $0.09 per share, above the Zacks Consensus Estimate of $0.08. Earnings were $0.01 per share a year ago.

Why it matters — RXO watchers may note that quarterly earnings exceeded the consensus estimate and were higher than a year earlier.

RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains

Business Wire · 29 Oct 2026positive

RXO reported strong third-quarter results, exceeding the high end of its profit outlook. The company said it continued to gain market share in Brokerage, increased truckload volume 3% while outperforming the market, and raised truckload spot mix by 900 basis points sequentially.

Why it matters — The update highlights RXO's reported profit performance and operating trends in Brokerage and truckload.

Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock

Zacks Investment Research · 22 Oct 2026positive

Zacks Investment Research said RXO passed its “Fast-Paced Momentum at a Bargain” screen, which identifies stocks with recent momentum that it considers reasonably priced.

Why it matters — The item highlights RXO’s recent momentum and the screen’s assessment of its valuation.

FAQ

Frequently asked questions about RXO stock

What is the RXO stock price forecast for 2026-2027?

The 18 Wall Street analysts covering RXO, Inc. have a median 12-month price target of $30, with estimates ranging from $19 to $33. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is RXO stock a buy right now?

Of the 18 analysts covering RXO, Inc., 3 rate it a Buy, 15 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks RXO, Inc. 72 out of 100 across roughly 4,600 US stocks as at 31 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank RXO?

As at 31 Oct 2026, RXO, Inc. ranks 72 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (95 of 100).

Will RXO stock go up?

No one can know that. What the data says: the median 12-month target from 18 analysts implies +9.1% from the last close, and Ticker Nerd's factor model ranks RXO, Inc. 72 out of 100 as at 31 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the RXO stock forecast for 2030?

No analyst covering RXO, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RXO are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $19 to $33 over the next 12 months.

How has RXO stock performed over the past year?

RXO, Inc. returned +59.1% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does RXO, Inc. do?

RXO Inc. is an asset-light transportation and logistics company that specializes in truck brokerage, managed transportation, last mile delivery, and freight forwarding.

What is the latest news on RXO?

The most recent item we track (GlobeNewsWire, 30 Oct 2026): "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)". Brodsky & Smith announced that it is reminding investors about an investigation involving RXO Inc., alongside investigations involving ADT, PTC and Lifecore Biomedical. The notice invites RXO shareholders to contact the firm to discuss the investigation.

Company

About RXO, Inc.

RXO Inc. is an asset-light transportation and logistics company that specializes in truck brokerage, managed transportation, last mile delivery, and freight forwarding. RXO connects shippers with third-party carriers through technology-driven platforms and service teams, helping manage freight movement across truckload, middle mile, ocean, air, and customs-related services. The company serves a broad range of industries, including retail, consumer goods, manufacturing, food and beverage, and industrials, with a focus on improving freight coordination and supply chain efficiency. Headquartered in Charlotte, North Carolina, RXO plays a significant role in the North American transportation market as a brokered transportation platform built around scale, digital visibility, and access to carrier capacity.

CEO Mr. Drew M. Wilkerson · 6,906 employees · United States · https://www.rxo.com